Nordic Biostim
A fully automatic wearable device that preserve muscle mass and enhance recovery during hospitalization.
A fully automatic wearable device that preserve muscle mass and enhance recovery during hospitalization.
Muscle loss in bedridden patients is a critical issue, leading to prolonged recovery, reduced quality of life, and increased healthcare costs due to extended hospital stays and intensive rehabilitation. Existing solutions for muscle preservation are often invasive, uncomfortable, or impractical for long-term use, limiting their effectiveness and adoption.
Nordic Biostim is an advanced, fully automatic wearable device designed to address this challenge. Utilizing cutting-edge neuromuscular electrical stimulation (NMES) technology integrated into a textile-based system, PMPS delivers precise and effective stimulation to prevent muscle atrophy in immobilized patients. Unlike traditional methods, it is non-invasive, comfortable, and user-friendly, ensuring seamless operation with minimal caregiver involvement.
Clinically validated, Nordic Biostim has proven its ability to preserve muscle mass and support faster recovery, offering a superior alternative to existing technologies. By preventing muscle atrophy, it directly enhances patient outcomes and holds the potential to reduce hospital stays. Its autonomous functionality makes it ideal not only for clinical environments but also for “hospital-at-home” settings, enabling effective muscle preservation outside traditional care facilities. This versatility helps alleviate the strain on healthcare systems while improving patient access to advanced care solutions.
With its unique combination of innovative technology, clinical efficacy, and ease of use, Nordic Biostim represents a new standard in healthcare. Focused on commercialization, it is poised to transform patient recovery and rehabilitation, offering a scalable and cost-effective solution to one of healthcare’s most pressing challenges.
This project is supported by Spin-outs Denmark, a unique program that invests in researchers who create more impact by starting research-based companies.